HNB
IONS icon

Huntington National Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Huntington National Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.1K Sell
681
-14
-2% -$1.1K ﹤0.01% 1324
2025
Q4 		$55K Buy
695
+41
+6% +$3.09K ﹤0.01% 1209
2025
Q3 		$42.8K Sell
654
-141
-18% -$6.88K ﹤0.01% 1325
2025
Q2 		$31.4K Sell
795
-298
-27% -$9.75K ﹤0.01% 1412
2025
Q1 		$33K Buy
1,093
+142
+15% +$4.65K ﹤0.01% 1348
2024
Q4 		$33.2K Buy
951
+627
+194% +$23.4K ﹤0.01% 1370
2024
Q3 		$13K Buy
324
+2
+0.6% +$93 ﹤0.01% 1669
2024
Q2 		$15.3K Sell
322
-41
-11% -$1.68K ﹤0.01% 1545
2024
Q1 		$15.7K Buy
363
+74
+26% +$3.53K ﹤0.01% 1542
2023
Q4 		$14.6K Buy
289
+90
+45% +$4.31K ﹤0.01% 1518
2023
Q3 		$9.03K Hold
199
– – ﹤0.01% 1597
2023
Q2 		$8.16K Buy
199
+102
+105% +$3.92K ﹤0.01% 1632
2023
Q1 		$3.47K Buy
97
+96
+9,600% +$3.6K ﹤0.01% 1829
2022
Q4 		$38 Hold
1
– – ﹤0.01% 2508
2022
Q3 		$0 Hold
1
– – ﹤0.01% 2193
2022
Q2 		$0 Hold
1
– – ﹤0.01% 2215
2022
Q1 		$0 Hold
1
– – ﹤0.01% 2182
2021
Q4 		$0 Sell
1
-13
-93% -$409 ﹤0.01% 2142
2021
Q3 		$0 Buy
14
+13
+1,300% +$490 ﹤0.01% 1890
2021
Q2 		$0 Sell
1
-62
-98% -$2.43K ﹤0.01% 1804
2021
Q1 		$3K Hold
63
– – ﹤0.01% 1523
2020
Q4 		$4K Buy
63
+62
+6,200% +$3.09K ﹤0.01% 1430
2020
Q3 		$0 Hold
1
– – ﹤0.01% 1613
2020
Q2 		$0 Hold
1
– – ﹤0.01% 1602
2020
Q1 		$0 Sell
1
-350
-100% -$19.5K ﹤0.01% 1665
2019
Q4 		$21K Buy
351
+105
+43% +$6.26K ﹤0.01% 1237
2019
Q3 		$15K Hold
246
– – ﹤0.01% 1187
2019
Q2 		$16K Buy
246
+1
+0.4% +$71 ﹤0.01% 1211
2019
Q1 		$20K Sell
245
-393
-62% -$25.4K ﹤0.01% 1123
2018
Q4 		$34K Buy
638
+392
+159% +$20K ﹤0.01% 975
2018
Q3 		$13K Sell
246
-520
-68% -$24.4K ﹤0.01% 1330
2018
Q2 		$32K Sell
766
-559
-42% -$24.8K ﹤0.01% 1095
2018
Q1 		$58K Buy
1,325
+95
+8% +$4.83K ﹤0.01% 915
2017
Q4 		$62K Hold
1,230
– – ﹤0.01% 918
2017
Q3 		$62K Buy
1,230
+130
+12% +$6.81K ﹤0.01% 916
2017
Q2 		$56K Buy
1,100
+1,026
+1,386% +$47.8K ﹤0.01% 916
2017
Q1 		$3K Sell
74
-26
-26% -$1.17K ﹤0.01% 1329
2016
Q4 		$5K Hold
100
– – ﹤0.01% 1297
2016
Q3 		$4K Hold
100
– – ﹤0.01% 1386
2016
Q2 		$2K Hold
100
– – ﹤0.01% 1415
2016
Q1 		$6K Hold
100
– – ﹤0.01% 1548
2015
Q4 		$6K Hold
100
– – ﹤0.01% 1430
2015
Q3 		$4K Hold
100
– – ﹤0.01% 1553
2015
Q2 		$6K Hold
100
– – ﹤0.01% 1573
2015
Q1 		$6K Buy
+100
New +$6.79K ﹤0.01% 1557

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Huntington National Bank's IONS Position: Q1 2026 in Review

Huntington National Bank reduced its Ionis Pharmaceuticals (IONS) stake by 2% in Q1 2026, selling an estimated $1.1K and leaving 681 shares worth $51.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Huntington National Bank first reported a position in IONS in Q1 2015 and has held it in 45 quarters since. The position peaked at $62K in Q4 2017. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Huntington National Bank held 681 shares of Ionis Pharmaceuticals worth $51.1K as of Q1 2026.
  • Huntington National Bank sold 14 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.1K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1324 holding.
  • Huntington National Bank first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 45 quarters since.
  • Huntington National Bank's Ionis Pharmaceuticals position peaked at $62K in Q4 2017.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.